Ramirez, Cristina .
HRN: 26-79-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2025
CEFUROXIME 1.5GM (VIAL)
03/16/2025
03/23/2025
IVT
1.5 Gm
Q 24h
Fracture, Open, Comminuted, Distal 3rd Tibia, Right Sec To MVA
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes